Tsima Abou Kors, Linda Hofmann, Annika Betzler, Kathrina Payer, Martin Bens, Jens Truong, Adrian von Witzleben, Jaya Thomas, Johann M Kraus, Randa Kalaajieh, Diana Huber, Jasmin Ezić, Julian Benckendorff, Jens Greve, Patrick J Schuler, Christian H Ottensmeier, Hans A Kestler, Thomas K Hoffmann, Marie-Nicole Theodoraki, Cornelia Brunner, Simon Laban
Patients with oropharyngeal squamous cell carcinoma (OPSCC) caused by human papilloma virus (HPV) exhibit a better prognosis than those with HPV-negative OPSCC. This study investigated the distinct molecular pathways that delineate HPV-negative from -positive OPSCC to identify biologically relevant therapeutic targets. Bulk mRNA from 23 HPV-negative and 39 -positive OPSCC tumors (n = 62) was sequenced to uncover the transcriptomic profiles. Differential expression followed by gene set enrichment analysis was performed to outline the top enriched biological process in the HPV-negative compared to -positive entity...
February 8, 2024: Cancer Res Commun